➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Colorcon
Express Scripts
McKesson
Dow

Last Updated: June 17, 2021

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020520


Email this page to a colleague

« Back to Dashboard

NDA 020520 describes ZANTAC 75, which is a drug marketed by Sanofi Us and is included in two NDAs. It is available from two suppliers. Additional details are available on the ZANTAC 75 profile page.

The generic ingredient in ZANTAC 75 is ranitidine hydrochloride. There are forty-three drug master file entries for this compound. Eighty suppliers are listed for this compound. Additional details are available on the ranitidine hydrochloride profile page.
Summary for 020520
Tradename:ZANTAC 75
Applicant:Sanofi Us
Ingredient:ranitidine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 020520
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZANTAC 75 ranitidine hydrochloride TABLET;ORAL 020520 NDA JC World Bell Wholesale Co., Inc. 50269-222 50269-222-25 25 PACKET in 1 BOX (50269-222-25) > 1 TABLET in 1 PACKET
ZANTAC 75 ranitidine hydrochloride TABLET;ORAL 020520 NDA Navajo Manufacturing Company Inc. 67751-152 67751-152-01 1 POUCH in 1 CARTON (67751-152-01) > 1 TABLET, COATED in 1 POUCH

Profile for product number 001

Active Rx/OTC/Discontinued:OTCDosage:TABLET;ORALStrengthEQ 75MG BASE
Approval Date:Dec 19, 1995TE:RLD:Yes

Expired US Patents for NDA 020520

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Us ZANTAC 75 ranitidine hydrochloride TABLET;ORAL 020520-001 Dec 19, 1995   Get Started Free   Get Started Free
Sanofi Us ZANTAC 75 ranitidine hydrochloride TABLET;ORAL 020520-001 Dec 19, 1995   Get Started Free   Get Started Free
Sanofi Us ZANTAC 75 ranitidine hydrochloride TABLET;ORAL 020520-001 Dec 19, 1995   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Merck
McKinsey
Baxter
Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.